About Leuprolide
Continuous GnRH receptor stimulation causes receptor desensitization and downregulation. This suppresses LH/FSH → testosterone/estrogen to castrate levels. Short-term pulsatile use can transiently stimulate the axis before suppression occurs.
A synthetic GnRH agonist that paradoxically suppresses gonadotropin release with continuous administration via receptor downregulation. FDA-approved for prostate cancer, endometriosis, and uterine fibroids. Used off-label in men's health for HPG axis restart protocols.
Research Areas
Regulatory & Evidence
Risk Profile
Higher risk profile in research contexts. Review all contraindications carefully. Not suitable for self-administration without professional oversight.
Regulatory Status
- Availability Status
- Prescription
Regulatory status reflects publicly available information and may change. This is not legal or medical advice.
Safety Notes
Higher risk profile in research contexts. Professional oversight recommended.
Reported contraindications & considerations
Consult a qualified healthcare professional before making any health decisions. This information is educational only and does not constitute medical advice.
Where to Find Leuprolide
2 providersClinics
1 providerOnline Vendors
1 providerFrequently Asked Questions — Leuprolide
A synthetic GnRH agonist that paradoxically suppresses gonadotropin release with continuous administration via receptor downregulation. FDA-approved for prostate cancer, endometriosis, and uterine fibroids.
HPG axis modulation, testosterone suppression, hormonal restart, GnRH axis control.
2 providers in the directory currently offer Leuprolide.